Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo

Published:2014-05 Issue:4 Volume:447 Page:602-608
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Chian Song,Thapa Ruby,Chi Zhexu,Wang Xiu Jun,Tang Xiuwen

Funder

National Natural Science Foundation of China

Science Technology Department of Zhejiang Province

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis;Khor;Cancer Res.,2006

2. Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma;Mahaffey;Free Radic. Biol. Med.,2009

3. Mechanistic studies of the Nrf2-Keap1 signaling pathway;Zhang;Drug Metab. Rev.,2006

4. Discovery of the negative regulator of Nrf2, Keap1: a historical overview;Itoh;Antioxid. Redox Signal.,2010

5. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents;Magesh;Med. Res. Rev.,2012

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation on the antiviral activity of luteolin against largemouth bass virus;Aquaculture;2025-01

2. NRF2 inhibitors: Recent progress, future design and therapeutic potential;European Journal of Medicinal Chemistry;2024-12

3. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Journal of Pharmacology;2024-10

4. Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence;Biomedicine & Pharmacotherapy;2024-07

5. Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer;Frontiers in Oncology;2024-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3